Press release
Intra-Uterine Contraceptive Devices Market Professional Analysis on Industry Trends 2025 – Bayer, Teva Pharmaceuticals, DKT International, OCON Medical, MedWOW, Medicines360, Allergan, Agile Therapeutics
Intra-Uterine Contraceptive Devices Market
The Global Intra-Uterine Contraceptive Devices Market 2018 to 2025 renders deep perception of the key regional market status of the Drone Analytics Industry on a global level that primarily aims the core regions which comprises of continents like North America, Europe, Asia-Pacific, South America, Rest of the World.
Global Intra-Uterine Contraceptive Devices Market By Product Type (Copper IUCD, Hormonal IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 5289.17 million by 2025, at a CAGR of 4.1% during the forecast period of 2018 to 2025.
Download PDF Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market
Global Intra-Uterine Contraceptive Devices Market
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly economical, effective, and safe birth control devices. Their major role is that they prevent pregnancy for a long period of time and prevent the chances of ectopic pregnancy. They are considered to be 99.0% effective in preventing pregnancy. There are two types of intrauterine devices copper-releasing intrauterine devices and progesterone-releasing intrauterine devices. Copper-releasing intrauterine device works by releasing copper. This copper enhances the inflammatory reaction in the uterus which prevents fertilization of eggs. Progesterone-releasing intrauterine device works by releasing progestin, which thickens the cervical mucus and creates the barrier to sperms.
In 2016, The U.S. Food and Drug Administration pharms approved Bayer AG’s low dose levonorgestrel-releasing intrauterine system. It marketed in the United States under the brand name KyleenaTM. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine system for up to five years. This is very effective protection against pregnancy, using the smallest T-shaped body available today.
Allergan in 2016 launched single-handed Liletta IUD inserter.
To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com
Key Questions Answered in Global Intra-Uterine Contraceptive Devices Market Report:-
Our Report offers:-
• What will the market growth rate, Overview and Analysis by Type of Global Intra-Uterine Contraceptive Devices Market in 2025?
• What are the key factors driving, Analysis by Applications and Countries Global Intra-Uterine Contraceptive Devices Market?
• What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Intra-Uterine Contraceptive Devices Market?
• Who are Opportunities, Risk and Driving Force of Global Intra-Uterine Contraceptive Devices Market?
• Who are the opportunities and threats faced by the vendors in Global Intra-Uterine Contraceptive Devices Market? Business Overview by Type, Applications, Gross Margin and Market Share
• What are the Global Intra-Uterine Contraceptive Devices Market opportunities, market risk and market overview of the Market?
Segmentation: Global Intra-Uterine Contraceptive Devices Market
The global market for intra-uterine contraceptive devices by the following sub-categories is
presented
By Product Type
• Copper IUCD
• Hormonal IUCD
By End-User
• Hospitals
• Gynecology Clinics
• Community Healthcare
By Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa
To Buy Complete Report Click Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market
FACTORS DRIVING GROWTH IN THE GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET
The increased rate of unplanned pregnancies:
The rate of unintended pregnancy is increasing year after year, and the government initiatives regarding birth control and use of intra-uterine contraceptive devices in on the rise.
In 2010, at least 36.0% of pregnancies in every United States were unintended. In 2011, nearly half (45.0% or 2.8 million) of the 6.1 million pregnancies in the United States were unintended. In 2011, there were 45 the rate of unintended pregnancies was 45 per 1,000 women in an aged group between 15years –44years. According to a journal published by the lancet global health, 15·6 million abortions (14·1 million–17·3 million) occurred in India in 2015. The rate of abortion was 47 per 1000 women. 3.4 million Abortion occur in health facilities (22.0%). 11.5 million abortion abortions were done through medication (73.0%), 2.2 million abortions were surgical (14.0%).
According to national center for biotechnology information, in 2012 there were 85 million reported pregnancies, out of which 40.0% of all pregnancies were unintended. Of these, 50.0% ended in abortion, 13.0% ended in miscarriage, and 38.0% resulted in an unplanned birth.
Some of the major market players in this market are –
Bayer AG, Teva Pharmaceutical Industries Ltd, Mona Lisa N.V., DKT INTERNATIONAL, OCON Medical Ltd, Pregna International Limited, MedWOW Global, SMB Corporation of India, Meril Life Sciences Pvt. Ltd, GYNEAS, Melbea Innovations, Meril Life Sciences Pvt. Ltd, Melbea AG, Medicines360, ALLERGAN, Agile therapeutics Inc. among others.
Key Reasons to Purchase:
• To gain insightful analyses of the market and have comprehensive understanding of the Global Intra-Uterine Contraceptive Devices Market and its commercial landscape.
• Assess the Intra-Uterine Contraceptive Devices production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the Intra-Uterine Contraceptive Devices Market and its impact in the Global market.
• Learn about the market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for Global Intra-Uterine Contraceptive Devices Market.
Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-intra-uterine-contraceptive-devices-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intra-Uterine Contraceptive Devices Market Professional Analysis on Industry Trends 2025 – Bayer, Teva Pharmaceuticals, DKT International, OCON Medical, MedWOW, Medicines360, Allergan, Agile Therapeutics here
News-ID: 1173064 • Views: …
More Releases from Data Bridge Market Research
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period.
Market Overview
This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market…
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.
Market Overview
Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind…
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview
Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which…
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand…
More Releases for Contraceptive
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede
As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the…
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid…
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost…
